The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Nanotechnology Applications in Cancer
Abstract
Cancer nanotechnology is an interdisciplinary area of research in science, engineering, and medicine with broad applications for molecular imaging, molecular diagnosis, and targeted therapy. The basic rationale is that nanometer-sized particles, such as semiconductor quantum dots and iron oxide nanocrystals, have optical, magnetic, or structural properties that are not available from molecules or bulk solids. When linked with tumor targeting ligands such as monoclonal antibodies, peptides, or small molecules, these nanoparticles can be used to target tumor antigens (biomarkers) as well as tumor vasculatures with high affinity and specificity. In the mesoscopic size range of 5–100 nm diameter, nanoparticles also have large surface areas and functional groups for conjugating to multiple diagnostic (e.g., optical, radioisotopic, or magnetic) and therapeutic (e.g., anticancer) agents. Recent advances have led to bioaffinity nanoparticle probes for molecular and cellular imaging, targeted nanoparticle drugs for cancer therapy, and integrated nanodevices for early cancer detection and screening. These developments raise exciting opportunities for personalized oncology in which genetic and protein biomarkers are used to diagnose and treat cancer based on the molecular profiles of individual patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, high dose chemotherapy is necessary to overcome such limitations, which usually increases the risk of adverse effects (Nie et al., 2007).”
From The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer (2019) · cites this paper as Nie et al., 2007
In the citing paper
“Unfortunately, the major cause for the marginal effect elicited by some chemotherapeutic agents result from poor physicochemical properties, low bioavailability, and poor tissue selectivity (Nie et al., 2007).”
From The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer (2019) · cites this paper as Nie et al., 2007
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Research works printed but not linked: 124
- 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
- 10.1038/nrc795 · DOI
- 10.1038/35049567 · DOI
- 10.1038/nrd891 · DOI
- 10.1097/00001703-200002000-00007 · DOI
- 10.1038/labinvest.3780460 · DOI
- 10.1021/cr00098a010 · DOI
- 10.1021/cr00016a002 · DOI
- 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.3.CO;2-J · DOI
- 10.1038/nbt927 · DOI
- 10.1126/science.271.5251.933 · DOI
- 10.1146/annurev.bioeng.7.060804.100432 · DOI
- 10.1016/j.biomaterials.2005.11.018 · DOI
- 10.1126/science.1104274 · DOI
- 10.1016/j.copbio.2004.11.003 · DOI
- 10.1562/0031-8655(2004)080<0377:QDNFIV>2.0.CO;2 · DOI
- 10.1016/S0958-1669(02)00282-3 · DOI
- 10.1126/science.1070200 · DOI
- 10.1016/S1367-5931(02)00372-1 · DOI
- 10.1126/science.294.5540.137 · DOI
- 10.1038/nmat702 · DOI
- 10.1073/pnas.0236044100 · DOI
- 10.1126/science.297.5586.1536 · DOI
- 10.1126/science.286.5439.531 · DOI · Paper page
- 10.1038/73432 · DOI · Paper page
- 10.1038/35000501 · DOI · Paper page
- 10.1038/35021093 · DOI
- 10.1038/35020115 · DOI
- 10.1038/35090585 · DOI
- 10.1016/S0002-9440(10)64244-7 · DOI
- Rhodes DR, 2002, Cancer Res., 62, 4427
- 10.1093/jnci/95.9.661 · DOI
- 10.1002/path.892 · DOI
- 10.1097/00000478-200203000-00004 · DOI
- 10.1001/jama.287.13.1662 · DOI
- 10.1056/NEJMra021562 · DOI
- Gonzalgo ML, 2003, Clin. Cancer Res., 9, 2673
- 10.1038/nrd1497 · DOI
- 10.1038/nature02626 · DOI
- 10.1016/S0361-090X(02)00092-2 · DOI
- Srinivas PR, 2002, Clin. Chem., 48, 1160
- 10.1021/cm034081k · DOI · Paper page
- 10.1021/ja0434331 · DOI
- 10.1038/nbt994 · DOI
- Ntziachristos V, 2003, Eur. Radiol., 13, 195, 10.1007/s00330-002-1524-x · DOI
- 10.1073/pnas.0401137101 · DOI
- 10.1021/bc034151d · DOI
- 10.1021/bc049905i · DOI
- 10.1021/nl035010n · DOI
- 10.1021/ja0496423 · DOI
- 10.1021/nl051935m · DOI
- 10.1021/bc0600463 · DOI
- 10.1023/A:1020398624602 · DOI
- 10.1016/0168-3659(94)90152-X · DOI
- 10.3109/08982100009031113 · DOI
- 10.1021/bc0499127 · DOI
- 10.1016/j.cbpa.2004.08.011 · DOI
- Matsumura Y, 1986, Cancer Res., 46, 6387
- 10.1038/nrd1088 · DOI
- 10.1146/annurev.bioeng.1.1.241 · DOI
- 10.1016/S0168-3659(01)00306-6 · DOI
- 10.1021/bc034153y · DOI
- 10.1126/science.1083780 · DOI
- 10.1038/nm1247 · DOI
- 10.1038/nbt920 · DOI
- 10.1073/pnas.152463399 · DOI
- 10.1177/002215540305100801 · DOI
- Jain RK, 1999, Clin. Cancer Res., 5, 1605
- 10.1073/pnas.1735443100 · DOI
- 10.1097/01.ju.0000091655.77601.0c · DOI
- 10.1021/nl0347334 · DOI
- 10.1002/smll.200500105 · DOI
- 10.1021/nl047996m · DOI · Paper page
- 10.1038/nbt929 · DOI
- 10.1038/nbt764 · DOI
- 10.1046/j.1365-2818.2003.01219.x · DOI
- 10.1152/ajpregu.00449.2005 · DOI
- 10.1016/j.ceb.2005.08.001 · DOI
- 10.1073/pnas.93.26.15152 · DOI
- Hernandez I, 2003, Mol. Cancer Res., 1, 1036
- 10.1002/pros.20153 · DOI
- 10.1117/1.2032458 · DOI · Paper page
- 10.1056/NEJMoa040766 · DOI
- 10.1016/S0090-4295(02)02291-4 · DOI
- 10.1021/ja049384+ · DOI
- 10.1126/science.1088755 · DOI
- 10.1073/pnas.0406368102 · DOI
- 10.1126/science.1062711 · DOI
- 10.1021/nl034853b · DOI
- 10.1038/nbt1138 · DOI
- 10.1038/27873 · DOI
- 10.1038/77332 · DOI
- 10.1021/ja031723w · DOI
- 10.1038/nnano.2006.170 · DOI
- 10.1126/science.8128245 · DOI
- 10.1002/polc.5070510111 · DOI · Paper page
- 10.1016/S0169-409X(02)00021-2 · DOI
- 10.1016/S0167-7799(00)01485-2 · DOI
- 10.1016/j.biomaterials.2004.04.008 · DOI
- 10.1016/S0169-409X(97)00095-1 · DOI
- Mansour AM, 2003, Cancer Res., 63, 4062
- 10.1021/ar9703241 · DOI
- 10.1038/nrc903 · DOI
- 10.1111/j.1349-7006.2004.tb03219.x · DOI
- 10.1016/S0169-409X(00)00071-5 · DOI
- 10.1016/S0959-8049(05)80025-5 · DOI
- 10.1016/S0163-7258(99)00073-X · DOI
- Links M, 1999, Expert Rev. Mol. Med., 1999, 1
- 10.1016/S0928-0987(00)00114-7 · DOI
- 10.1016/j.jconrel.2003.08.005 · DOI
- 10.1038/bjc.1997.362 · DOI
- 10.1016/S1471-4914(03)00111-4 · DOI
- 10.2169/internalmedicine.42.237 · DOI
- 10.1016/j.addr.2004.01.008 · DOI
- 10.1016/S1359-6446(00)01594-4 · DOI
- 10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P · DOI
- 10.1016/S0928-0987(02)00251-8 · DOI
- 10.1021/bm0300655 · DOI
- 10.1074/jbc.M003120200 · DOI
- 10.1038/364464a0 · DOI
- 10.1016/S0378-5173(01)00986-3 · DOI
- 10.1093/jnci/96.2.90 · DOI
- 10.1016/S0959-8049(01)00171-X · DOI
- 10.1016/j.tibtech.2005.11.006 · DOI
Cited by
Sorted by citations
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201
Self-citationNanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
Etheridge, M. L., Campbell, S. A., Erdman, A. G., Haynes, C. L., Wolf, S. M., & McCullough, J. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.05.013 · Cited by 1,088
Recent Advances in Biosensor Technology for Potential Applications – An Overview
Vigneshvar, S., Sudhakumari, C. C., Senthilkumaran, B., & Prakash, H. (2016) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2016.00011 · Cited by 674
“…semiconductor quantum dots and iron oxide nanocrystals having optical as well as magnetic properties can be effectively linked with tumor targeting ligands, such as monoclonal antibodies, peptides, or small molecules to target tumor antigens with high affinity and specificity (Nie et al., 2007).”
BackgroundMultifunctional polymeric micelles for delivery of drugs and siRNA
Jhaveri, A. M., & Torchilin, V. P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00077 · Cited by 466
Polymeric micelles: nanocarriers for cancer-targeted drug delivery
Zhang, Y., Huang, Y., & Li, S. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0113-z · Cited by 367
Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy
Gindy, M. E., & Prud'homme, R. K. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902932908 · Cited by 298
Remote Optical Switch for Localized and Selective Control of Gene Interference
Lee, S. E., Liu, G. L., Kim, F., & Lee, L. P. (2009) · Nano Letters · doi:10.1021/nl802689k · Cited by 224
Mo, J., He, L., Ma, B., & Chen, T. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b11730 · Cited by 159
Alomrani, A., Badran, M., Harisa, G. I., ALshehry, M., Alhariri, M., Alshamsan, A., & Alkholief, M. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.02.008 · Cited by 143
Neurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
Zuchowska, A., Marciniak, K., Bazylinska, U., Jastrzebska, E., Wilk, K. A., & Brzozka, Z. (2018) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2018.08.037 · Cited by 22
Metadata
- Authors
- Nie, S., Xing, Y., Kim, G. J., & Simons, J. W.
- Affiliations
- Department of Biomedical Engineering and the Winship Cancer Institute, Emory University and Georgia Institute of Technology, Atlanta, Georgia 30322;
- Venue
- Annual Review of Biomedical Engineering
- Publisher
- Annual Reviews
- Published
- 2007-08-15
- Volume
- 9
- Issue
- 1
- Pages
- 257-288
- ISSN
- 1523-9829
- 1545-4274
- Cited by
- 952
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review